Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04667598
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04667598
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04667598. Randomized; no masking; primary purpose treatment. Start 2020-12-15 (anticipated); primary completion 2022-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
- Condition
- Heart Failure
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Modified Wenxin Decoction
- Lead sponsor
- Jun Li
Record details
- Record id
cardio:ct-nct04667598- Content hash
349a4ed5de2a2a15b791e5b7f2e5520738678299b4b35664a838eb2017795dac